查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2055206

聚合物生物材料市場：按產品、應用和地區分類

Polymeric Biomaterials Market, By Product, By Application (Cardiovascular, Dental, Orthopedic, Plastic Surgery, Neurology and Others), By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到2026年，聚合物基生物材料市場規模將達到766.2億美元，2033年將達到1,952.7億美元。預計從2026年到2033年，該市場將以14.3%的複合年成長率成長。

報告範圍 報告詳情
基準年： 2025 2026年市場規模： 766.2億美元
歷史數據時期： 2020年至2024年 預測期： 2026年至2033年
2026年至2033年預測期間的複合年成長率： 14.30% 2033年市場規模預測： 1952.7億美元

聚合物生物材料是指具有生物相容性的聚合物，廣泛應用於醫療領域和醫療設備。由於其生物分解性和生物相容性，它們在組織工程和再生醫學領域中發揮著至關重要的作用。聚合物生物材料包括天然聚合物，例如膠原蛋白和彈性蛋白，以及合成聚合物，例如聚乙醇酸（PGA）、聚乳酸（PLA）和聚己內酯（PCL）。這些聚合物具有可調控的理化性質和分解行為，使其成為藥物傳遞載體、醫療植入和組織再生支架的理想候選材料。聚合物生物材料在心血管、整形外科、牙科和創傷治療領域的日益廣泛的應用，正以驚人的速度推動全球聚合物生物材料市場的發展。

市場動態

全球聚合物生物材料市場的主要驅動力是慢性病盛行率的上升、老年人口的成長以及醫療植入和組織工程手術的日益普及。根據聯合國預測，65歲及以上人口將從2021年的7.03億增加到2050年的15億。人口老化預計將推動對用於植入、組織支架和其他醫療應用的聚合物生物材料的需求成長。此外，具有可調分解特性的新型生物可吸收聚合物的開發、加工技術的多樣化以及再生醫學研究的進步也促進了市場成長。然而，嚴格的監管核准流程和高成本可能會阻礙市場擴張。儘管如此，新興經濟體醫療保健投資的增加和醫療技術的不斷進步預計將在預測期內創造新的機會。

本次調查的主要特點

  • 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
  • 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據以下參數介紹了全球聚合物生物材料市場主要公司的概況：公司亮點、產品系列、關鍵亮點、財務表現和策略。
  • 透過利用本報告中的見解，企業負責人和經營團隊將能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球聚合物生物材料市場報告的目標受群眾外包括行業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過分析全球聚合物基生物材料市場中使用的各種策略矩陣輕鬆做出決策。

目錄

第1章：研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

  • 市場動態
    • 在整形外科和牙科領域不斷拓展應用。
    • 嚴格的法規環境
    • 亞太地區和拉丁美洲的新興市場
  • 主要亮點
  • 監管趨勢
  • 近期趨勢
  • PEST分析
  • 波特的分析
  • 併購和合作

第4章 全球聚合物生物材料市場：依產品分類，2021-2033年

  • 聚乳酸（PLA）
  • 聚乙醇酸（PGA）
  • 聚氨酯
  • 聚四氟乙烯（PTFE）和發泡聚四氟乙烯（ePTFE）
  • 聚芳醚醚酮（PEEK）
  • 氧環己酮聚合體（PDO）
  • 其他

第5章 全球聚合物生物材料市場：依應用領域分類，2021-2033年

  • 心血管系統
  • 牙科
  • 整形外科
  • 整形外科
  • 神經病學
  • 其他

第6章 全球聚合物生物材料市場：依地區分類，2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第7章 競爭情勢

  • 公司簡介
    • Stryker
    • BASF SE
    • Evonik Industries AG
    • DSM
    • Bezwada Biomedical, LLC
    • Corbion
    • Victrex plc（Invibio Ltd.）
    • International Polymer Engineering
    • Covalon Technologies Ltd.
    • Medtronic
    • Abbott
    • Elixir Medical
    • REVA Medical, LLC
    • Meril Life Sciences Pvt. Ltd.
    • MicroPort Scientific Corporation
  • 分析師意見

第8章

  • 參考
  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI6533

Polymeric Biomaterials Market is estimated to be valued at USD 76.62 Bn in 2026 and is expected to reach USD 195.27 Bn by 2033, growing at a compound annual growth rate (CAGR) of 14.3% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 76.62 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 14.30% 2033 Value Projection: USD 195.27 Bn

Polymeric biomaterials are polymers that are biocompatible and are used in medical applications and devices. They plays an important role in tissue engineering and regenerative medicine applications due to their biodegradability and biocompatibility properties. Polymeric biomaterials can be natural polymers such as collagen, elastin or synthetic polymers like polyglycolic acid(PGA), polylactic acid (PLA) or polycaprolactone (PCL). These polymers are attractive candidates for drug delivery vehicles, medical implants, and scaffolds for tissue regeneration due to their tunable physicochemical properties and degradation behavior. Global polymeric biomaterials market is growing at a significant rate due to the increasing use of polymeric biomaterials in cardiovascular, orthopedic, dental and wound healing applications.

Market Dynamics

Global polymeric biomaterials market is primarily driven by the rising prevalence of chronic diseases, growing geriatric population, increasing medical implants and tissue engineering procedures. According to the United Nations, the number of people aged 65 years and above is projected to grow from 703 Mn in 2021 to 1.5 billion by 2050. The increase in ageing population is expected to boost the demand for polymeric biomaterials used in implants, tissue scaffolds and other medical applications. Moreover, development of novel bioabsorbable polymers with tunable degradation properties, versatility in processing techniques and increasing research in regenerative medicine also helps to fuel the market growth. However, stringent regulatory approval process and high costs associated with research and development (R&D) could hamper the market expansion. Nevertheless, growing healthcare investments in emerging nations and ongoing advancements in medical technology are projected to unlock new opportunities over the forecast period.

Key features of the study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global polymeric biomaterials market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Stryker, BASF SE, Evonik Industries AG, DSM, Bezwada Biomedical, LLC, Corbion, Victrex plc (Invibio Ltd.), International Polymer Engineering, Covalon Technologies Ltd., Medtronic, Abbott, Elixir Medical, REVA Medical, LLC, Meril Life Sciences Pvt. Ltd., and MicroPort Scientific Corporation.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global polymeric biomaterials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global polymeric biomaterials market.

Market Segmentation

  • Global Polymeric Biomaterials Market, By Product (Revenue, USD Bn, 2021 - 2033)
  • Polylactic Acid (PLA)
  • Polyglycolic Acid (PGA)
  • Polyurethanes
  • Polytetrafluoroethylene (PTFE) & Expanded Polytetrafluoroethylene (ePTFE)
  • Polyaryletheretherketone (PEEK)
  • Polydioxanone (PDO)
  • Others
  • Global Polymeric Biomaterials Market, By Application (Revenue, USD Bn, 2021 - 2033)
  • Cardiovascular
    • Bioresorbable Stents
    • Vascular Grafts
    • Sensors
    • Guidewires
    • Implantable Cardiac Defibrillators
    • Pacemakers
    • Others
  • Dental
    • Tissue Regeneration Materials
    • Dental Implants
    • Bone Grafts & Substitutes
    • Dental Membranes
    • Dental Sutures
    • Others
  • Orthopedic
    • Joint Replacement Polymeric Biomaterials
    • Tissue Fixation Products
      • Suture Anchors
      • Others
    • Orthobiologics
    • Viscosupplementation
    • Spine Biomaterials
    • Others
  • Plastic Surgery
    • Facial Wrinkle Treatment
    • Soft Tissue Fillers
    • Craniofacial Surgery
      • Sutures
      • Others
    • Bioengineered Skins
    • Peripheral Nerve Repair
    • Acellular Dermal Matrices
    • Others
  • Neurology
    • Neural Stem Cell Encapsulation
    • Shunting Systems
    • Hydrogel Scaffold For CNS Repair
    • Cortical Neural Prosthetics
    • Others
  • Others
  • Global Polymeric Biomaterials Market, By Region (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Top Companies in the Global Polymeric Biomaterials Market
  • Stryker
  • BASF SE
  • Evonik Industries AG
  • DSM
  • Bezwada Biomedical, LLC
  • Corbion
  • Victrex plc (Invibio Ltd.)
  • International Polymer Engineering
  • Covalon Technologies Ltd.
  • Medtronic
  • Abbott
  • Elixir Medical
  • REVA Medical, LLC
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Polymeric Biomaterials Market, By Product
    • Global Polymeric Biomaterials Market, By Application
    • Global Polymeric Biomaterials Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing orthopedic and dental applications
    • Stringent regulatory environment
    • Emerging markets in Asia Pacific and Latin America
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions, and Collaborations

4. Global Polymeric Biomaterials Market, By Product, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Polylactic Acid (PLA)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
  • Polyglycolic Acid (PGA)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
  • Polyurethanes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
  • Polytetrafluoroethylene (PTFE) & Expanded Polytetrafluoroethylene (ePTFE)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
  • Polyaryletheretherketone (PEEK)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
  • Polydioxanone (PDO)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)

5. Global Polymeric Biomaterials Market, By Application, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Cardiovascular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
      • Bioresorbable Stents
      • Vascular Grafts
      • Sensors
      • Guidewires
      • Implantable Cardiac Defibrillators
      • Pacemakers
      • Others
  • Dental
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
      • Tissue Regeneration Materials
      • Dental Implants
      • Bone Grafts & Substitutes
      • Dental Membranes
      • Dental Sutures
      • Others
  • Orthopedic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
      • Joint Replacement Polymeric Biomaterials
      • Tissue Fixation Products
        • Suture Anchors
        • Others
      • Orthobiologics
      • Viscosupplementation
      • Spine Biomaterials
      • Others
  • Plastic Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
      • Facial Wrinkle Treatment
      • Soft Tissue Fillers
      • Craniofacial Surgery
        • Sutures
        • Others
      • Bioengineered Skins
      • Peripheral Nerve Repair
      • Acellular Dermal Matrices
      • Others
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
      • Neural Stem Cell Encapsulation
      • Shunting Systems
      • Hydrogel Scaffold For CNS Repair
      • Cortical Neural Prosthetics
      • Others
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)

6. Global Polymeric Biomaterials Market, By Region, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2033
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(USD Bn)
      • North Africa
      • Central Africa
      • South Africa

7. Competitive Landscape

  • Company Profile
    • Stryker
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • BASF SE
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Evonik Industries AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • DSM
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Bezwada Biomedical, LLC
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Corbion
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
      • Strategies
    • Victrex plc (Invibio Ltd.)
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • International Polymer Engineering
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Covalon Technologies Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Medtronic
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Abbott
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Elixir Medical
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • REVA Medical, LLC
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Meril Life Sciences Pvt. Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • MicroPort Scientific Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
  • Analyst Views

8. Section

  • References
  • Research Methodology
  • About us